Recall Z-0201-2022— Medtronic Neuromodulation
Class II · Ongoing
Class II FDA medical device recall by Medtronic Neuromodulation, initiated 2021-09-23. FDA's recall record names no specific 510(k) clearance for this event. Product: Clinician Programmer Application (CPA) model A610 Clinician Software Application. Reason: A software anomaly may occur with the clinician programmer application..
- Recalling firm
- Medtronic Neuromodulation
- Classification
- Class II
- Status
- Ongoing
- Initiated
- 2021-09-23
- Firm location
- Minneapolis, MN, United States
Product description
Clinician Programmer Application (CPA) model A610 Clinician Software Application
Reason for recall
A software anomaly may occur with the clinician programmer application.
Data sourced from openFDA. This site is unofficial and independent of the FDA.